302 related articles for article (PubMed ID: 16805423)
1. Agonists and antagonists for P2 receptors.
Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
[TBL] [Abstract][Full Text] [Related]
2. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
3. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
5. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
[TBL] [Abstract][Full Text] [Related]
6. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
7. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
8. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.
Houston D; Costanzi S; Jacobson KA; Harden TK
Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269
[TBL] [Abstract][Full Text] [Related]
9. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.
Jacobson KA; Costanzi S; Ohno M; Joshi BV; Besada P; Xu B; Tchilibon S
Curr Top Med Chem; 2004; 4(8):805-19. PubMed ID: 15078212
[TBL] [Abstract][Full Text] [Related]
11. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.
Costanzi S; Mamedova L; Gao ZG; Jacobson KA
J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977
[TBL] [Abstract][Full Text] [Related]
12. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
[TBL] [Abstract][Full Text] [Related]
15. Participation of peripheral P2Y1, P2Y6 and P2Y11 receptors in formalin-induced inflammatory pain in rats.
Barragán-Iglesias P; Mendoza-Garcés L; Pineda-Farias JB; Solano-Olivares V; Rodríguez-Silverio J; Flores-Murrieta FJ; Granados-Soto V; Rocha-González HI
Pharmacol Biochem Behav; 2015 Jan; 128():23-32. PubMed ID: 25449358
[TBL] [Abstract][Full Text] [Related]
16. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.
Andó RD; Méhész B; Gyires K; Illes P; Sperlágh B
Br J Pharmacol; 2010 Mar; 159(5):1106-17. PubMed ID: 20136836
[TBL] [Abstract][Full Text] [Related]
19. Molecular pharmacology of P2Y-receptors.
von Kügelgen I; Wetter A
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
[TBL] [Abstract][Full Text] [Related]
20. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
